Entity
  • Genethon

    Created in 1990
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    147 878 21,506
  • Activities

  • Entity types

  • Location

    1 Rue de l'internationale, 91000 Évry-Courcouronnes, France

    Évry-Courcouronnes

    France

  • Employees

    Scale: 51-200

    Estimated: 294

  • SIREN

    402187520
  • Engaged corporates

    10
    3 9
  • Added in Motherbase

    5 years, 2 months ago
Description
  • Value proposition

    Généthon, centre de R&D préclinique et clinique de médicaments de thérapie génique.

    Created in 1990 and funded by AFM-TELETHON, Genethon, a pioneer in deciphering the human genome and identifying the genes associated with genetic diseases is today fully dedicated to the design and development of gene therapy treatments for rare diseases.

    At Genethon more than 180 scientists, clinicians and engineers specialized in gene therapy drug development, from research to the clinic, have joined forces in order to provide these innovative treatments to patients affected with rare disorders. These treatments also pave the way for new therapeutic approaches for frequent disorders.

    In 2012 Genethon received the Prix Galien France for pharmaceutical research into “Medicines destined for rare diseases – cell therapy and gene therapy.”

    In 2013 Genethon’s production facility, Genethon BioProd obtained certification as a pharmaceutical manufacturer from French National agency for medicines and health products safety (ANSM). Genethon BioProd is the largest laboratory for GMP production of gene therapy products in the world.

    In april 2015 Genethon was recipient of the Global Innovation Competition 2030 in the category “Risk Lift” at the Elysee Palace, for its project on the development of an industrial process for production of gene therapy vectors.

    gene therapy, rare genetic disease, and clinical trials

  • Original language

    Généthon, centre de R&D préclinique et clinique de médicaments de thérapie génique.

    Created in 1990 and funded by AFM-TELETHON, Genethon, a pioneer in deciphering the human genome and identifying the genes associated with genetic diseases is today fully dedicated to the design and development of gene therapy treatments for rare diseases.

    At Genethon more than 180 scientists, clinicians and engineers specialized in gene therapy drug development, from research to the clinic, have joined forces in order to provide these innovative treatments to patients affected with rare disorders. These treatments also pave the way for new therapeutic approaches for frequent disorders.

    In 2012 Genethon received the Prix Galien France for pharmaceutical research into “Medicines destined for rare diseases – cell therapy and gene therapy.”

    In 2013 Genethon’s production facility, Genethon BioProd obtained certification as a pharmaceutical manufacturer from French National agency for medicines and health products safety (ANSM). Genethon BioProd is the largest laboratory for GMP production of gene therapy products in the world.

    In april 2015 Genethon was recipient of the Global Innovation Competition 2030 in the category “Risk Lift” at the Elysee Palace, for its project on the development of an industrial process for production of gene therapy vectors.

  • Généthon - Des médicaments de thérapie génique pour maladies rares

    Généthon développe des thérapies géniques innovantes pour les maladies rares neuromusculaires, du système immunitaire, du sang, du foie et de la vision

  • https://www.genethon.fr/
Corporate interactions BETA
Corporate TypeTweets Articles
CNRS
CNRS
Research, Research Services
CNRS
Research, Research Services
Other

4 Sep 2024


France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

19 Apr 2024


Thales
Thales
Defence and Aerospace, IT Services and IT Consulting
Thales
Defence and Aerospace, IT Services and IT Consulting
Other

29 Jul 2023


Bpifrance
Bpifrance
Bank, Banking
Bpifrance
Bank, Banking
Other

18 Feb 2024


Leem
Leem
Startup accelerator & VC, Pharmaceutical Manufacturing
Leem
Startup accelerator & VC, Pharmaceutical Manufacturing
Other

10 Oct 2024


Greater Paris University Hospitals - AP-HP
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Other

9 Jun 2020

17 Aug 2023



Medicen Paris Region
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations
Not capitalistic
Not partnership
Event

18 Feb 2019

5 Jul 2024



BFM Business
BFM Business
Media, Broadcast Media Production and Distribution
BFM Business
Media, Broadcast Media Production and Distribution
Not capitalistic
Not partnership
Event

22 Apr 2021


Genopole
Genopole
Biotechnology, Biotechnology Research
Genopole
Biotechnology, Biotechnology Research
Not capitalistic
Partnership
Event

19 Apr 2022

27 Jun 2024



Sanofi
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Not capitalistic
Partnership
Not event

10 Mar 2022


Similar entities
Loading...
Loading...
Social network dynamics